A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

Stopped early · Phase 4

Conditions studied: Renal Transplant Rejection

In brief

This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.

Key facts

Study ID

NCT00983645

Run by

Loma Linda University

People needed

15

Starts

2004-10-01

Expected to finish

2013-03-01

Last updated by the study team

2016-06-03

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cadaveric or Living Donors
• 18 years old or greater
• Primary renal transplants
• Hispanic ethnicity

You may not qualify if…

• Prior renal transplant
• Multi-organ transplant
• Recipient with history of Diabetes Mellitus
• PRA > 20%
• Cold Ischemia Time > 24 hours

Where it is running

• Loma Linda University Medical Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.